Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vopratelimab |
| Trade Name | |
| Synonyms | JTX2011|JTX-2011 |
| Drug Descriptions |
Vopratelimab (JTX-2011) is a humanized monoclonal antibody against ICOS (inducible co-stimulator molecule) that regulates anti-tumor immune response (Cancer Res 2016;76(14 Suppl):Abstract nr 573). |
| DrugClasses | ICOS Antibody 6 |
| CAS Registry Number | 2039148-04-2 |
| NCIT ID | C129876 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ipilimumab + Vopratelimab | Ipilimumab Vopratelimab | 0 | 2 |
| Nivolumab + Vopratelimab | Nivolumab Vopratelimab | 0 | 2 |
| Vopratelimab | Vopratelimab | 0 | 2 |